GAPDH and non-small cell lung carcinoma: The presence of CTCs in advanced NSCLC was assessed by combining EpCAM-based immunoisolation and RT-qPCR analysis of GAPDH in a series of 42 advanced NSCLC patients (Supplementary Table S1) and 16 healthy donors.